Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial

Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T10:35:28.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the usual study details, with a minimal header and a Home button. This indicates restricted access to the record rather than an update to the study information.
    Difference
    21%
    Check dated 2026-09-22T12:34:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    New study-contact and site entries were added: Sarah Richman, MD and Arthur M Blank Hospital - Children's Healthcare of Atlanta on 2026-09-02 and 2026-08-31. An earlier entry for Neena Kapoor, MD at Arthur M. Blank Hospital (Pediatrics) was removed on 2026-07-31 and 2026-07-29.
    Difference
    0.2%
    Check dated 2026-09-08T01:00:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page's revision tag updates from v3.6.5 to v3.6.6, indicating a minor version update in the site's metadata. This change does not affect the study details or user-visible content.
    Difference
    0.0%
    Check dated 2026-08-31T23:24:30.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page revision has been updated to version v3.6.5, indicating a small metadata update to the study record.
    Difference
    0.0%
    Check dated 2026-08-10T22:09:32.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page now lists a new Data Protection Officer with contact details, while several previous contacts and investigators’ information were removed, reflecting a revision of how to reach the study team.
    Difference
    0.6%
    Check dated 2026-08-03T19:23:20.000Z thumbnail image

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.